Here’s a summary of the ContagionLive article “Non‑Targeted Hepatitis C Screening in Emergency Departments Increases Diagnoses” (published July 21, 2025):
🧬 Findings from the DETECT Hep C Trial
1. Study Design & Rationale
- The DETECT Hep C trial was a large pragmatic randomized clinical trial conducted across three urban emergency departments—Denver, Baltimore, and Jackson, Mississippi.
- It compared non‑targeted (universal opt‑out) HCV screening to targeted (risk‑based) screening integrated into routine ED workflows.
2. Screening Outcomes
- Non‑targeted group (73,847 patients):
• 13.4% (9,867) were tested, leading to 154 new diagnoses. - Targeted group (73,651 patients):
• 6.3% (4,640) were tested, resulting in 115 new diagnoses. - This represented a 34% relative increase in new diagnoses with non‑targeted screening (relative risk ≈1.34; 95% CI 1.05–1.70; P = .02).
3. Why EDs Matter
- Emergency departments serve as safety-net healthcare sites for underserved and vulnerable populations who may otherwise lack access to primary care.
- These settings create critical opportunities to reach individuals at high risk of HCV who may never be screened in other settings.
4. Challenges in Care Continuum
- Despite higher diagnostic yield, both screening strategies had poor downstream outcomes:
- Linkage to care: ~19.5% in non-targeted vs ~24.3% in targeted.
- Treatment initiation (DAA): ~15.6% vs ~17.4%.
- Completion of treatment: ~12.3% vs ~12.2%.
- Sustained virologic response at 12 weeks (SVR12): ~9.1% vs ~9.6%.
- The authors stress a major gap between diagnosis and cure, emphasizing the need for innovative linkage-to-care strategies from the ED setting.
5. Broader Implications
- The trial supports updated CDC guidelines recommending universal HCV screening for all adults 18+ in high-prevalence settings.
- It demonstrates how real-world, clinic-integrated research can expand detection and reduce missed diagnoses—especially among populations disproportionately affected by healthcare access barriers.
✅ Bottom Line
- Non‑targeted, opt‑out HCV screening in emergency departments identifies significantly more new infections than traditional targeted strategies (34% more diagnoses).
- However, few individuals navigate the full continuum from diagnosis to cure.
- This underscores the need for better post-diagnosis outreach, linkage-to-care protocols, and treatment support embedded within emergency care systems.